Cancer Pioneer Dies

Janet Rowley, who earned fame for linking chromosomal abnormalities to cancer in the 1970s, has passed away at age 88 from ovarian cancer.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Janet RowleyNATIONAL LIBRARY OF MEDICINECancer researcher Janet Rowley, who spent most of her career at the University of Chicago, where she earned her MD in 1948 at the age of 23, died on Tuesday (December 17) in her home in the Hyde Park neighborhood just south of the city. Widely decorated for her contributions in oncology and genetics, Rowley continued to work until just a few months ago, even riding her bike to campus, The Washington Post reported.

The cause of Rowley’s death was ovarian cancer complications, according to a university statement. She was 88.

“Janet Rowley’s work established that cancer is a genetic disease,” Mary-Claire King, professor of medical genetics at the University of Washington and president of the American Society of Human Genetics, told UChicago News. “She demonstrated that mutations in critical genes lead to specific forms of leukemia and lymphoma, and that one can determine the form of cancer present in a patient directly from the genetic changes in the cancer. We are still working from her paradigm.”

Rowley was 15 when she earned a scholarship to an accelerated educational program at the University of Chicago. When she entered the university’s med school, she was one of just three women ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours